Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Clynes

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Biotechnology Progress|April 25, 2019
Improvements in single-use bioreactor film material composition leads to robust and reliable Chinese hamster ovary cell performancePaul S Kelly, Noemi Dorival-García, Samantha Paré, et al.
Blood|June 18, 2014
A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapyKerstin Pohl, Elaine Hayes, Joanne Keenan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 1, 2011
A novel neutrophil derived inflammatory biomarker of pulmonary exacerbation in cystic fibrosisEmer P Reeves, David A Bergin, Sean Fitzgerald, et al.
Ebiomedicine|August 25, 2017
Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung DiseaseMichelle M White, Patrick Geraghty, Elaine Hayes, et al.
International Journal of Molecular Sciences|February 7, 2020
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma PatientsSandra Roche, Fiona O'Neill, Jean Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2024
Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft TumorsTista Roy Chaudhuri, Qingxiang Lin, Ewa K Stachowiak, et al.
Biotechnology and Bioengineering|March 6, 2012
Utilization and evaluation of CHO-specific sequence databases for mass spectrometry based proteomicsPaula Meleady, Raimund Hoffrogge, Michael Henry, et al.
Proteomes|November 9, 2018
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour XenograftsOrla Coleman, Michael Henry, Fiona O'Neill, et al.
Life (Basel, Switzerland)|March 29, 2023
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These TumorsFiona O'Neill, Taylor-Jade Allen-Coyle, Sandra Roche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomibMelissa G Ooi, Patrick J Hayden, Vassiliki Kotoula, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Biotechnology Progress|April 25, 2019
Improvements in single-use bioreactor film material composition leads to robust and reliable Chinese hamster ovary cell performancePaul S Kelly, Noemi Dorival-García, Samantha Paré, et al.
Blood|June 18, 2014
A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapyKerstin Pohl, Elaine Hayes, Joanne Keenan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 1, 2011
A novel neutrophil derived inflammatory biomarker of pulmonary exacerbation in cystic fibrosisEmer P Reeves, David A Bergin, Sean Fitzgerald, et al.
Ebiomedicine|August 25, 2017
Neutrophil Membrane Cholesterol Content is a Key Factor in Cystic Fibrosis Lung DiseaseMichelle M White, Patrick Geraghty, Elaine Hayes, et al.
International Journal of Molecular Sciences|February 7, 2020
Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma PatientsSandra Roche, Fiona O'Neill, Jean Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2024
Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft TumorsTista Roy Chaudhuri, Qingxiang Lin, Ewa K Stachowiak, et al.
Biotechnology and Bioengineering|March 6, 2012
Utilization and evaluation of CHO-specific sequence databases for mass spectrometry based proteomicsPaula Meleady, Raimund Hoffrogge, Michael Henry, et al.
Proteomes|November 9, 2018
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour XenograftsOrla Coleman, Michael Henry, Fiona O'Neill, et al.
Life (Basel, Switzerland)|March 29, 2023
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These TumorsFiona O'Neill, Taylor-Jade Allen-Coyle, Sandra Roche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Interactions of the Hdm2/p53 and proteasome pathways may enhance the antitumor activity of bortezomibMelissa G Ooi, Patrick J Hayden, Vassiliki Kotoula, et al.
Pageof 20